ロード中...
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS
OBJECTIVE: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. METHODS: In this multicenter, double-blind, placebo-controlled trial (TOFINGO), patients with relapsing-remittin...
保存先:
| 出版年: | Neurology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501941/ https://ncbi.nlm.nih.gov/pubmed/26024899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001706 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|